United States Patent (19) 11) Patent Number: 4,619,829 Motschan 45 Date of Patent: Oct
Total Page:16
File Type:pdf, Size:1020Kb
United States Patent (19) 11) Patent Number: 4,619,829 Motschan 45 Date of Patent: Oct. 28, 1986 4,386,072 5/1983 Horrobin et al. ................... 424/127 54 UTILIZATION OF ASINGLEVITAMINORA COMBINATION OF WARIOUS VTAMNS 4,387,093 6/1983 Lysaght .......... ... 424/1.31 4,439,454 3/1984 Riva .................................... 424/329 76 Inventor: Georges Motschan, Schönbeinstrasse 21, 4056 Basel, Switzerland OTHER PUBLICATIONS 21 Appl. No.: 631,555 Chem. Abst., 72, 99038q, (1970)-Guglielmi et al. Chem. Abst, 74,73981h, (1971)-Fukui. 22, PCT Filed: Nov. 16, 1983 Chem Abst, 76,21283d, (1972)-Alter et al. 86 PCT No.: PCT/CH83/00127 Chem. Abst, 76, 70679(w), (1972)-Kurmaeva et al. Chem. Abst., 81, 131090z, (1974)-Nash. S371 Date: Jul. 13, 1984 Chem. Abst., 90, 70869x, (1979)-Miskinite et al. S 102(e) Date: Jul. 13, 1984 Chem. Abst., 90, 145621w, (1979)-Wilkins et al. "The Healing Factor'-Irwine Stone-1972-pp. 87 PCT Pub. No.: WO84/01899 108-112. PCT Pub. Date: May 24, 1984 Primary Examiner-Douglas W. Robinson 30 Foreign Application Priority Data Attorney, Agent, or Firm-Ostrolenk, Faber, Gerb & Nov. 16, 1982 CH Switzerland ......................... 6682/82 Soffen 51) Int. Cl.' .................... A61K 31/525; A61K 33/42 57 ABSTRACT 52) U.S.C. ................................... 424/128; 514/251; The invention refers to a new utilization of a unique 514/825; 514/904; 514/905 vitamin or a combination of various vitamins in the 58 Field of Search ............... 514/276, 251, 825, 904, long-term treatment and/or prevention of rheumatic 514/905; 424/128 diseases. 56) References Cited During a long-term treatment and/or prevention of U.S. PATENT DOCUMENTS rheumatic diseases, a unique vitamin or a combination 1,261,995 4/1918 Ampt ................................... 424/355 of various vitamins is administered to a patient. 2,816,854 12/1957 Gross ..... ... 424/143 4,206,222 6/1980 Valetas ................................ 424/279 9 Claims, No Drawings 4,619,829 1 2 It is of the utmost importance that an application in UTILIZATION OF A SINGLE VITAMEN OR A conformity with the invention is a long-term therapy, in COMBINATION OF WARIOUS VITAMNS conformity with the invention. The expression "long term therapy” ordinarily depends on the degree of the The present invention refers to a new utilization of a disease to be treated, the general state of health of the single or a combination of various vitamins in the long patient, his body weight and his age. The expert will term therapy and/or prophylaxis of rheumatic diseases easily find out how long the treatment has to last until and a method for a long-term therapy and/or prophy improvement or complete healing is achieved. If need laxis of rheumatic diseases. be, the daily administration of the active substance or of Rheumatic diseases are widespread illnesses. In the 10 the combination of active substances can be interrupted USA alone about 30 million people suffer from arthritis, for a specific period of time, for instance 1 week or 1 vide TIME MAGAZINE nr. 33, page 41, of Aug. 16, month or longer and can subsequently be resumed at the 1982. In the "Bulletin on the Rheumatic Diseases', vol. same, an increased or a decreased rate. Depending on 32, nr. 1 (1982), page 1, published by the Arthritis Foun the specificity of the patient's individuality, it has been dation, 3400 Peachtree Road, N.E. Atlanta, Ga. 30326, 15 found, priority has to be given to a long-term therapy of well-known therapies of rheumatoid arthritis are de not less than 5 months, especially not less than 6 scribed. months, preferably 1 year, and better still not less than The active substances collectively denominated Vita 2 years. In some cases, it appears to be of the utmost mins are known, vide for example "Chemie Lexikon' advantage for the patient if the long-term treatment by Prof. Dr. Hermann Römpp, Franckh'sche Verlag 20 lasts for life. shandlung, Stuttgart. Special preference is to be given to the long-term, It is described in the literature that neither short-term regular, continuous, uninterrupted and daily applica administration of vitamins nor high-level doses and/or tion, in conformity with the invention, of an active so-called massive doses result in improvement in cases substance or a combination of active substances in con of rheumatoid arthritis; vide "Arthritis and Allied Con 25 formity with the invention, in order to achieve healing ditions. A Textbook of Rheumatology'. Editor: Joseph and/or stoppage and/or prevention (prophylaxis) of a Lee Hollander, M.D., Seventh Edition. Published (in rheumatic disease, especially of a polyarthritis in gen Europe) by Henry Kimpton, London, 1966, especially eral and of a primary chronical polyarthritis. chapter 37, "Diet and Vitamins in Rheumatoid Arthri Preferably the vitamin or vitamins belong to the tis', by Ronald Lamont-Havers, M.D. 30 vitamin-B-complex; regarding this term's definition the Completely surprisingly, it now was found that rheu above mentioned "Chemie Lexikon' for example serves matic diseases can very successfully be treated by ad as reference. ministration of at least one vitamin over a long period of The application of the vitamin or a combination of time, be it prophylactically, for improvement and/or vitamins can be, in conformity with the invention, con recovering. 35 bined and supplemented with a mineral and/or trace The present invention refers to a new application of a element and/or at least an additive, especially carriers, single or a combination of various vitamins in the long antioxidants, bacteriostats. term therapy and/or prophylaxis of rheumatic diseases, Following hereunder the specific newly applicable especially such of inflammatory and degenerative na compounds, in conformity with the invention, are de ture, which involve joints, muscles, tendines and other 40 scribed, their synonyms, their biological preliminary parts of the locomotive system. Examples of such dis stages (if any) and their chemical denominations: eases are the inflammations of joints, chronical polyar thritis, a primary chronical polyarthritis and a general VITAMINA arthritis, especially a chronical and/or acute arthritis. Synonyms: The word “Polyarthritis' has hereafter to be inter 45 Retinol preted as a collective expression for all possible forms of Axerophtol appearances of this disease(s) and its aetiology(ies), be it Antixerophtalmic vitamin rheumatoid arthritis, primary chronical polyarthritis, Antiinfectuous vitamin osteoarthritis or any of the more than 100 other forms Skin protecting vitamin and variations, symptoms and syndromes of this disease. 50 Growth vitamin Hereafter the supreme and collective expression polyar Biological preliminary stages: thritis will be used. a-6-y-Carotin The long-term therapy can be applied in any way; the Cryptoxanthin (3-Hydroxy-3-carotin) systemic, injection and the topical administrations are Echineon (4-oxo-f3-carotin) preferred. Above all, however, the most preferable is 55 Citroxanthin (Mutatochrome; (3-carotinoxide) the oral administration. The active substances acting as Myxoxanthin antirheumatic agents are administered orally and/or by Torularhodin injection in a dosage of about 0.25-2 mg/kg body Aphanin weight per day, preferably 0.5-1 mg/kg/per day, al Chemical Denominations: though higher or lower doses can be applied too and 60 easily determined by an expert, for example a physician. CH3 - In vitamin combinations, the quantities of the specific CH3 H vitamins can be varied. The dose can be administered as H C. C CH3CH3 CSa S1S a single-dose or be dispensed over several part-doses. Cs-CsC C s1 Hr. HeH CH3 CH3 For the preferred oral administration the customary 65 2 H CH3 2 modes are to be taken into consideration, such as cap CH3 sules, lacquered tablets or tablets. The manufacture of such modes of administration can be the customary one. all-trans-3-carotin 4,619,829 3 4. -continued 21 2'/ 5 Sa | N NH2 N 3-pyridine carboxamide all-trans-vitamin A1 = all-trans-3,7-dimethyi-9-(2,6,6'- trimethyl-1'-cyclohexen-l'-yl)-2,4,6,8-nonatetraen-1-ol 10 VITAMIN B6 Synonyms: CH CH CH3 CH3 3 H 3 Pyridoxine CNH C H C H CHCH2OH Adermin isSa C1 SSn c1 SS.c1 S.c1 Anti-acrodynic-factor CH3 15 Anti-dermatitis-factor Rat Pellagra Preventive Factor all-trans-vitamin A2 = 3',4'-Dehydrovitamin A1 Chemical Denominations: CH2OH VITAMIN B1 20 Synonyms: Ho-1 CH2OH Thiamine CH3-S Aneurine N Antineuritic vitamin 2-methyl-3-hydroxy-4,5-di(hydroxymethyl)-pyridine Anti-Beriberi-vitamin 25 Pyridoxole Beriberi Preventive Substance CHO Torulin Chemical Denomination HO 21 CH2OH 30 CH3-S N 2- -- N CH2-N CH3 2-methyl-3-hydroxy-4-formyl-5-hydroxymethyl-pyridine CH-ls NH2 Tason Pyridoxal N S CH2NH2 3-(4-amino-2-methylpyrimidyl-5-methyl)-4-methyl-5-6- 35 hydroxy-ethylthiazole Ho-21 CH2OH CH3 S. N VITAMIN B2 2-methyl-3-hydroxy-4-aminomethyl-5-hydroxymethyl-pyridine Synonyms: 40 Pyridoxamine Riboflavin The group of the 3 active substances Pyridoxole, Pyri Lactoflavin doxal, Pyridoxamine, all of which have vitamin-B6 ef Chemical Denomination: fects, are gathered under the denomination Pyridoxine. 45 OHOHOH PANTOTHENIC ACID Synonyms: Filtrate factor (H----CH-OHH. H. H. N N Bios IIa CH3 Y c=o 50 Bios III Chick-anti-dermatitis-factor CH3 e NH Anti-gray (hair)-factor N c1 Chemical Denominations: O 6,7-dimethyl-9-(D-1'-ribityl)-isoalloxazin 55 SH: HOCH2-C-CHOH-CO-NH-CH2-CH2-COOH NICOTINAMIDE CH3 Synonyms: Nicotinamide 60 D(+)-ay-dihydroxy-6, (3-dimethylbutyryl-3'-alanin Nicotylamide Niacinamide SH: Vitamin PP HOCH2-C-CHOH-CO-NH-CH2-CH2-CH2OH CH3 Pellagra Preventive Factor 65 PP Factor Pantothenyl alcohol (Panthenol) Pellagra preventive factor Salts: Pantothenic calcium (Calcium-D-Pantothenate) Chemical Denomination: 4,619,829 5 6 BIOTIN N N Synonyms: NH-1 raS COOH Vitamin H V Bios II 5 N N 1.